News Guidelines for Diagnosing Alzheimer’s

News Guidelines for Diagnosing Alzheimer’sThe guidelines for the diagnosis of Alzheimer’s, which includes new techniques for treatments, were announced on Tuesday by the United States. The new rules have been developed by the experts of National Institutes of Health, the NIA and the Alzheimer's Association, which was published by the journal of the Alzheimer's Association.

The new guidelines revealed that diagnosis of the disease includes three phases and it also made clear to people that the symptom of the disease is not just the memory loss.

In the nascent stages of the Alzheimer’s, people experience some early changes in the brain, which has adverse affects on almost 37 million people globally.

The new research has found out the treatments for the early identification of the diseases.

Meanwhile, it was revealed that the UK splurge eight times less on the research of Alzheimer’s in contrast to the cancer research.

The Director of National Institute on Aging (NIA), Richard Hodes said, "Bringing the diagnostic guidelines up to speed with those advances is both a necessary and rewarding effort that will benefit patients and accelerate the pace of research".

He also explained the three stages of the disease, in which first is preclinical stage, in which patients experience brain changes. The second phase, mild cognitive impairment, which is mainly for researchers to determine biomarkers.

At last the third phase, which involves the evaluation of causes and succession of patient’s brain changes.